Revive Therapeutics Ltd.

(TSXV:RVV) (OTC:RVVTF) (FRA:31R)

Company Description:

Revive Therapeutics Ltd. (TSXV:RVV) (OTC:RVVTF) is focused on the research, development and commercialization of novel treatments for serious and unmet medical needs by identifying and investigating potential drugs and plant-based therapies, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, combined with existing drugs, or be developed as new chemical entities or prodrugs.

Latest News & Stories on Revive Therapeutics Ltd. (TSXV:RVV) (OTC:RVVTF) (FRA:31R)

Revive Therapeutics Announces FDA Grants Orphan Drug Designation

June 27, 2018

Revive Therapeutics Sees Positive Results In Liver Disease Research

June 7, 2017

Revive To Sponsor Research at University of Wisconsin

May 30, 2017

Revive Therapeutics Provides Clinical Trial Update

March 29, 2017

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.